Tessera’s layoffs come amid broader biotech industry adjustments, with the company narrowing its research scope to core gene-editing efforts tied to its partnership with Regeneron and moving other projects
https://www.boston.com/news/business/2026/01/12/somerville-biotech-company-laying-off-35-of-workforce/